You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Primary Mediastinal Large B Cell Lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Mediastinal Large B-cell Lymphoma With CNS Involvement

Recruiting
  • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
    • Milan, Italy
      Ospedale San Raffaele
    Aug 29, 2023

    CNS Involvement in Primary Mediastinal Large B-Cell Lymphoma

    Active, not recruiting
    • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
    • DISEASE
    • (no location specified)
    May 4, 2023

    Primary Mediastinal Large B-cell Lymphoma (PMBCL), Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell

    Not yet recruiting
    • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
    • +5 more
    • Boston, Massachusetts
    • +1 more
    Jun 28, 2023

    Large B-cell Lymphoma, DLBCL, Not Otherwise Specified, Primary Mediastinal Large B-cell Lymphoma (PMBCL) Trial (Epcoritamab)

    Available
    • Large B-cell Lymphoma
    • +4 more
    • Epcoritamab
    • (no location specified)
    Feb 16, 2023

    Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

    Not yet recruiting
    • Non-hodgkin Lymphoma
    • +9 more
    • CD79b-19 CAR T cells
    • +2 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 6, 2023

    DLBCL (DLBCL), Primary Mediastinal Large B-cell Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)

    Active, not recruiting
    • Diffuse Large B-Cell Lymphoma (DLBCL)
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Lymphoma, B-Cell Trial in Japan (Pembrolizumab)

    Active, not recruiting
    • Lymphoma, B-Cell
    • Nagoya, Aichi, Japan
    • +8 more
    Aug 18, 2022

    B-cell Lymphoma, Non Hodgkin Lymphoma, DLBCL Trial in Louisville (Cyclophosphamide, Fludarabine, ACE1831)

    Recruiting
    • B-cell Lymphoma
    • +5 more
    • Louisville, Kentucky
      Norton Cancer Institute
    Jan 24, 2023

    Lentiviral-based Gene-edited Immune Cell Therapy

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma
    • +4 more
    • Pell's lentiviral-based gene-edited immune cell therapy
    • Kaohsiung, Taiwan
    • +2 more
    Oct 25, 2022

    Bio-CAR-T BS Study

    Recruiting
    • Diffuse Large B Cell Lymphoma (DLBCL)
    • +2 more
      • Brescia, Italy
        ASST Spedali Civili di Brescia
      May 5, 2022

      Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in United States (P-CD19CD20-ALLO1, Rimiducid)

      Not yet recruiting
      • Diffuse Large B Cell Lymphoma
      • +5 more
      • La Jolla, California
      • +7 more
      Aug 25, 2023

      Mediastinal Large B-cell Lymphoma, Richter Syndrome Trial (Pembrolizumab)

      Completed
      Has Results
      • Mediastinal Large B-cell Lymphoma
      • Richter Syndrome
      • Pembrolizumab
      • (no location specified)
      Oct 21, 2021

      Diffuse Large B Cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma, Large B-cell Lymphoma Trial in Kaohsiung, Taipei

      Recruiting
      • Diffuse Large B Cell Lymphoma
      • +4 more
      • CD19-targeted chimeric antigen receptor T-cell
      • Kaohsiung, Taiwan
      • +2 more
      Oct 25, 2022

      Mature B-Cell Tumor, Non Hodgkin Lymphoma, DLBCL Trial (SGR-1505)

      Not yet recruiting
      • Mature B-Cell Neoplasm
      • +25 more
      • (no location specified)
      Sep 14, 2022

      Diffuse Large-Cell Lymphoma, Primary Mediastinal Large B-Cell Lymphoma (PMBCL), Transformed Follicular Lymphoma (TFL) Trial in

      Recruiting
      • Diffuse Large-Cell Lymphoma
      • +3 more
      • Pneumococcal conjugate vaccine (PCV13)
      • CD19 targeted CAR T Cell Therapy
      • Tampa, Florida
        Moffitt Cancer Center
      May 31, 2022

      Non Hodgkin Lymphoma (NHL), Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL) Trial in Milwaukee (8/12-Day

      Recruiting
      • Non Hodgkin Lymphoma (NHL)
      • +6 more
      • 8/12-Day Production of Car-T Cells
      • +2 more
      • Milwaukee, Wisconsin
        Medical College of Wisconsin and Froedtert Hospital
      Jul 1, 2022

      Cardiovascular Events Among Adults Relapsed or Refractory

      Recruiting
      • Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma
      • +9 more
      • Electronic Health Record Review
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 5, 2022

      Anaplastic Large Cell Lymphoma, Peripheral T Cell Lymphoma, Extranodal NK/T-cell Lymphoma Trial in Duarte, Nashville, Houston

      Active, not recruiting
      • Anaplastic Large Cell Lymphoma
      • +4 more
      • Duarte, California
      • +3 more
      Jul 21, 2022

      B-cell Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Taipei (RPM

      Terminated
      • B-cell Acute Lymphoblastic Leukemia
      • +7 more
      • RPM CD19-mbIL15-CAR-T cells
      • Taipei, Taiwan
        National Taiwan University Hospital
      May 11, 2022

      Refractory Non-Hodgkin Lymphoma, Burkitt Lymphoma, Mantle Cell Lymphoma Trial in San Francisco (Fludarabine, Cyclophosphamide,

      Recruiting
      • Refractory Non-Hodgkin Lymphoma
      • +8 more
      • San Francisco, California
        University of California, San Francisco
      May 2, 2022

      Primary Mediastinal Large B-cell Lymphoma Trial in Lyon, Rouen (Circulating tumor DNA monitoring)

      Recruiting
      • Primary Mediastinal Large B-cell Lymphoma
      • Circulating tumor DNA monitoring
      • Lyon, France
      • +1 more
      Mar 29, 2021

      Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma, Ann Arbor Stage II Primary Mediastinal (Thymic) Large

      Recruiting
      • Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma
      • +3 more
      • Brentuximab Vedotin
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 10, 2022

      CAR T Cell Therapy Related Cardiovascular Outcomes

      Recruiting
      • Cardiovascular Diseases
      • +7 more
        • London, United Kingdom
          University College London Hospitals
        Nov 18, 2021

        Recurrent DLBCL, Recurrent Grade 3b Follicular Lymphoma, Recurrent High Grade B-Cell Lymphoma Trial in Duarte (Biopsy,

        Not yet recruiting
        • Recurrent Diffuse Large B-Cell Lymphoma
        • +11 more
        • Biopsy
        • +5 more
        • Duarte, California
          City of Hope Medical Center
        Jan 3, 2023

        Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic Hodgkin Lymphoma, Recurrent

        Not yet recruiting
        • Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
        • +21 more
        • Biopsy
        • +8 more
        • Columbus, Ohio
          Ohio State University Comprehensive Cancer Center
        Apr 7, 2023